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Abstract 
Coronavirus disease 2019 (COVID-19) is a pandemic viral disease caused by SARS-CoV-2 that generated serious damages 
for both the human population and the global economy. Therefore, it is currently considered as one of the most important 
global health problems of human societies and there is an urgent need for potent drugs or vaccines which can effectively 
combat this virus. The chymotrypsin-like protease (3CLpro) of SARS-CoV-2 plays a key role in the viral replication inside 
the host and thus is a promising drug target to design and develop effective antiviral drugs against SARS and other corona-
viruses. This study evaluated some antiviral coumarin phytochemicals as potential inhibitors of coronaviruses 3CLpro by in 
silico approaches such as molecular docking, ADMET prediction, molecular dynamics simulation, and MM-PBSA binding 
energy calculation. Natural coumarin derivatives were docked to the 3CLpro of SARS-CoV-2 and for further investigation, 
docked to the 3CLpro of SARS-CoV and MERS-CoV. The docking scores of these natural compounds were compared with 
3CLpro referenced inhibitors (ritonavir and lopinavir) and co-crystal inhibitor N3. Molecular docking studies suggested more 
than half of the coumarin phytochemicals had favorable interaction at the binding pocket of the coronaviruses 3CLpro and 
exhibited better binding affinities toward 3CLpro than ritonavir and lopinavir. Most antiviral phytochemicals interact strongly 
with one or both the catalytic dyad residues (His41 and Cys145) and the other key residues of SARS-CoV-2 main protease. 
Further, MD simulation and binding free energy calculations using MM-PBSA were carried out for three 3CLpro-coumarin 
complexes and 3CLpro-N3/lopinavir. The results confirmed that the 3CLpro-glycycoumarin, 3CLpro-oxypeucedanin hydrate, 
and 3CLpro-inophyllum P complexes were highly stable, experience fewer conformation fluctuations and share a similar 
degree of compactness. Also, the pharmacokinetics and drug-likeness studies showed good results for the selected coumarin 
phytochemicals.Therefore, the coumarin phytochemicals could be used as antiviral agents in the treatment of COVID-19 
after further studies.
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Abbreviations
COVID-19  Coronavirus disease 2019 pneumonia
SARS-CoV-2  Severe acute respiratory syndrome corona-
virus 2
MERS-CoV  Middle East respiratory syndrome 
coronavirus
SARS-CoV  Severe acute respiratory syndrome 
coronavirus
WHO  World Health Organization
3CLpro  3-Chymotrypsin-like protease
Mpro  Main protease enzyme
PLpro  Papain-like protease
HIV  Human immunodeficiency virus
MD  Molecular dynamics
PDB  Protein data bank
GROMACS  GROningen MaChine for chemical 
simulations
RMSD  Root-mean-square deviation
RMSF  Root-mean-square fluctuation
Rg  Radius of gyration
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SASA  Solvent accessible surface area
SPC  Simple point charge
MM-PBSA  Molecular Mechanic/Poisson–Boltzmann 
surface Area
Introduction
Coronaviruses (CoVs) are positive single-standard RNA 
viruses from the family Coronaviridae that can infect many 
hosts such as humans [1, 2]. The CoVs are placed within the 
subfamily orthocoronavirinae that categorized to four gen-
era, Alpha-coronavirus, Beta-coronavirus, Gamma-corona-
virus, and Delta-coronavirus [3, 4]. In the past two decades, 
two coronaviruses of the Beta-coronavirus family, includ-
ing Middle East respiratory syndrome coronavirus (MERS-
CoV) and severe acute respiratory syndrome coronavirus 
(SARS-CoV), are zoonotic coronavirus that have caused 
global outbreaks and infected 1 million humans worldwide 
[5, 6]. The 2019 novel zoonotic coronavirus (SARS-CoV-2) 
was first identified and described in Wuhan city, the capital 
of Hubei province of China in the year 2019 that declared as 
COVID-19 by the World Health Organization (WHO) [7, 8] 
and was rapidly spread almost in all countries of the world 
[9] and became a global pandemic [10].
Humans can be infected by a virus through direct expo-
sure to infected animals, direct contact human-to-infected 
humans with symptomatic or asymptomatic signs, and envi-
ronmental contamination such as surfaces contaminated with 
droplets from coughing and sneezing of the symptomatic 
patients [11, 12]. This disease can show wide clinical fea-
tures from asymptomatic state, mild, moderate to severe 
signs with multi-organ dysfunction in infected patients, such 
as respiratory symptoms like dry cough, running nose, diz-
ziness, shortness of breath which might further advance to 
pneumonia, fever, headache, tiredness, conjunctivitis, loss 
of taste or smell, a rash on the skin, or discoloration of fin-
gers or toes, aches, and pains, loss of speech or movement, 
malaise, and severe acute respiratory distress syndromes 
that causing death, also kidney failure with the fatal con-
sequence, gastrointestinal disorders, including looseness of 
the bowels and diarrhea, sepsis and septic shock [12–14].
One of the attractive drug targets among coronavirus 
has been proposed to be 3-Chymotrypsin-like protease 
(3CLpro), called the main protease enzyme (Mpro), which 
contribute crucially to the essential maturation and replica-
tion and thus controls proteolytic cleavage as well as the 
processing of the large viral polyprotein orf1ab in combi-
nation with the papain-like protease (PLpro) [15]. 3CLpro 
protein selected as a candidate target for pan-CoV drug 
development, because it is critical for the viral replication 
or virulence, and highly conserved across all known CoVs 
and considered likely to be conserved in emerging CoVs. 
Moreover, the three-dimensional structure of the 3CLpro 
(with 306 amino acids, 6LU7) of SARS-CoV-2 like other 
coronaviruses such as MERS-CoV and SARS-CoV with 40 
percent to 44 percent of the sequence homology involves 3 
functional domains, including domain I (residues 8–101) 
and domain II (residues 102–184) consisting of 2-β barrel 
fold, which is similar to the chymotrypsin with a Cys-His 
catalytic dyad (Cyc145 and His41) situated in the cleft of 
domain I and II for SARS-CoV-2 catalytic activity, wherein 
Cys works as a nucleophile whereas His functions as a 
proton acceptor; and domain III (residues 201–306) also 
involves 5 α-helices linked to domain II through a long-
loop area (residues 185 to 200) (Fig. S1) [16, 17]. The struc-
ture of 3CLpro complexed with a peptide-like inhibitor N3 
and residues like His41, Phe140, Leu141, Asn142, Gly143, 
Cys145, His163, Met165, his172 and Gln189 show non-
covalent interaction with N3 ligand. The ligand N3 forms 
hydrogen bonds (H-bond) with Gly143, Cys145, Glu166, 
and Gln189 residues in the binding pocket of this protease 
enzyme (Fig. S2) [18].
A key bicyclic heterocyclic is coumarin (2H-1-benzo-
pyran-2-one) that is a natural secondary metabolite (SM) 
extracted from fungus, plants, bacteria, chemical synthesis, 
as well as essential oils, has been examined as one of the 
prominent structures to develop novel agents with higher 
specificity and affinity to different molecular targets show-
ing antioxidant, anticancer, antiviral, anti-inflammatory and 
antileishmania activities [19–23]. Therefore, diverse fami-
lies of plants like Umbelliferae, Clusiaceae, and Rutaceae 
have been used to isolate coumarins [19]. Moreover, natural 
compounds, synthetic and semi-synthetic drugs have been 
used against molecular targets of many viral proteins for 
inhibiting viral outbreak, which possess lower side effects 
and toxicity. Hence, they would be worthwhile candidates in 
the fight against diverse viruses like Covid-19 [24].
A lot of investigations referred to the inhibition impacts 
of diverse classes of natural coumarin phytochemicals (Fig. 
S3) on the functioning of viral proteins such as protease, 
integrase, reverse transcriptase as well as DNA polymerase, 
also, preventing viral entry against a wide range of human 
viruses such as hepatitis B and C, influenza, human immu-
nodeficiency virus (HIV) and herpes simplex virus [19, 20, 
25]. Coumarin compounds with similar structures including 
saxalin, psoralen, and bergapten have been known to prevent 
HIV replication [26]. Also, coumarins of mesoul and isome-
soul have been reported to suppress HIV replication in jurkat 
T cell [27]. Kellerin, a sesquiterpene coumarin; rutamarin, a 
natural furanocoumarin; glycycoumarin, an aryl-coumarin, 
and osthole, a simple coumarin were reported to be anti-
HSV and anti-HCV agents [28, 29]. Also, other studies 
have reported that some of the natural coumarins such as 
xanthotoxin, glycycoumarin, oxypeucedanin, pranferol and 
heraclenol have anti-HIV activity [24, 30].
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In this study, we have investigated 50 natural coumarin 
phytochemicals isolated from plants to explore and identify 
the binding affinities and interactions of these phytochemi-
cals against the coronavirus 3CLpro by molecular modeling 
approaches. The best compounds selected based on binding 
affinity were further investigated by molecular dynamics 
(MD) simulations and binding free energy calculations in 
which the selected compounds may be used as inhibitors 
against 3CLpro of SARS-CoV-2 and Covid-19 disease.
Material and methods
Protein structure
The 3CLpro cleavage sites on the polyproteins of coronavi-
ruses are highly conserved, and their sequence and substrate 
specifications for coronaviruses of SARS-CoV-2, SARS-
CoV, and MERS-CoV are identical [31]. This sequential 
similarity provides the insight for comparing SARS-CoV-2 
with its previous counterparts leading to the identification 
of potent compounds to inhibit or control the replication of 
SARS- CoV-2. Therefore, the crystal structures of corona-
viruses 3CLpro which were used in the docking analysis 
with sequence similarity were taken from the protein data 
bank (PDB) (http:// www. rcsb. org) with the corresponding 
PDB identification codes [SARS-CoV-2 (6LU7), SARS-
CoV (2DUC) and MERS-CoV (2YNA)]. 6LU7, 2DUC and 
2YNA (PDB ID) were chosen as 3CLpro receptors because 
these have resolution values of 2.16, 1.70, and 1.50 Å, 
respectively. During the preparation process of the pro-
teins using the Molecular Operation Environment (MOE) 
software, their water molecules and original ligands were 
removed, while polar hydrogen’s and Gasteiger charges 
were added to each protein. The protein structures were 
minimized by the energy minimization algorithm of MOE 
using the MMFF94X force field with the conjugate gradient 
method. Then, the protein structures were saved for molecu-
lar docking studies.
Ligand preparation
Bioactive coumarin phytochemicals (50 compounds) from 
different aromatic and medicinal plants and the 3CLpro 
reference inhibitors (ritonavir and lopinavir) were retrieved 
in SDF format from the PubChem database (www. pubch 
em. ncbi. nlm. nih. gov) and ChemSpider (www. chems pider. 
com). Then, all the ligands and inhibitors were converted 
into MOL2 format using Chemoffice Bio 3D Ultra (ver-
sion 12.0, Cambridge Soft Corporation, Cambridge, 2010) 
and were optimized using AM1 semi-empirical method by 
Hyperchem software.
Molecular docking study
The molecular docking calculations were carried out using 
MOE software to predict the mode of interaction of the cou-
marin molecules and reference inhibitors with the active 
site of coronaviruses 3CLpro and to determine the binding 
affinities of these compounds with coronaviruses 3CLpro. 
Within MOE, the flexibility of ligands is considered while 
the proteins are considered as a rigid structure. Site finder 
[32–34] was used for the selection of the active site of the 
3CLpro protein and the active site was defined with at least 
one atom within a distance cut off of 4.5 Å at ligand in the 
crystal structure of 3CLpro. The docking was done using 
the triangle matcher placement algorithm in combination 
with the London dG scoring function and force field as the 
refinement method. The best conformation of the ligands 
was further evaluated by the binding energies (s-score, kcal/
mol), and interactions between the ligands and proteins were 
analyzed by the LigX module in MOE and UCSF chimera 
software.
Validation of docking
Docking protocol was validated by re-docking of the co-
crystalized ligand (N3) into the 3CLpro structure (6LU7). 
As can be seen in Fig. S4, N3 molecule bound into similar 
positions of 3CLpro in comparison with its original crystal-
lographic form and the docked structure had a RMSD of 
1.669 Å after superimposing onto the native co-crystallized 
complex which indicates the validity of the method used.
In silico evaluation of physicochemical 
and pharmacokinetics properties
Various pharmacokinetic properties of the best-identified 
phytochemicals and the reference inhibitors with signifi-
cant binding affinity for 3CLpro of SARA-CoV-2 were 
evaluated based on pharmacokinetics and physicochemical 
features such as drug-likeness rules (Lipinski [35], Veber 
[36], Egan [37], Ghose and Muegge [38]), lipophilicity (Log 
Po/w), water solubility, Log S, polar surface area (TPSA), 
number of rotatable bonds and medicinal chemistry (PAINS, 
Brenk, Lead likeness, synthetic accessibility) methods were 
analyzed using Swiss ADME and pkCSM-pharmacokinetics 
web tools. The canonical SMILES of the phytochemicals 
were copied from Chem Draw to calculate ADMET and 
drug likeness properties using default parameters. Also, the 
P450 site of metabolism (SOM), the PASS prediction, and 
the molecular target studies were calculated using RS-Web 





Pharmacophores constitute the main structural scaffold for a 
set of active compounds that is responsible for their biologi-
cal activity and is frequently being used in drug design ini-
tiatives. Pharmacophore mapping is used to find important 
features with a set of functional groups for receptor binding. 
The pharmacophore protocol of MOE has been used to con-
struct the most representative features of the glycycoumarin 
and 6LU7 active site, which are indicated as spheres that 
represent the pharmacophore of glycycoumarin and essential 
interaction points with the key residues on ligand binding 
of the 3CLpro.
Molecular dynamics simulation of 3CLpro 
of SARS‑CoV‑2
MD simulations are used for validation of molecular dock-
ing results and offer a reliable assessment of the potential 
stability of a protein–ligand complex [41]. In this study, 
MD simulations were carried out for the apo SARS-CoV-2 
3CLpro; 3CLpro complexed with co-crystal inhibitor N3 and 
lopinavir as control and the complexes of 3CLpro with three 
selected coumarin phytochemicals obtained from molecu-
lar docking studies, which helped to get more insight into 
protein and docked complexes in biological conditions. The 
MD simulations were carried out using the GROningen 
MaChine for chemical simulations (GROMACS, version 
5.1.2) with GROMOS96 43al force field [42–44] for 50 ns 
at the real physiological condition and aqueous solution 
at T = 310 K (37 °C) and P = 1 atm. The topology files of 
glycycoumarin, Inophyllum P, oxypeucedanin hydrate, N3, 
and lopinavir were obtained from the PRODRG server [45] 
while the topology file of 3CLpro protein was prepared by 
the GROMACS. The 3CLpro and 3CLpro-ligand systems 
were solvated and fully immersed in the dodecahedron box 
with simple point charge (SPC) waters and neutralized by 
adding four sodium ions and energy minimized using the 
steepest descent algorithm [1, 15, 18, 32] for 50,000 steps 
and energy tolerance of 500 kJ/mol in a periodic boundary 
condition and equilibrated to achieve the appropriate vol-
ume under NVT ensemble [46]. The particle-Mesh Ewald 
(PME) method was used with a Fourier grid spacing of 1 Å 
to calculate the long-range electrostatic interactions. The 
short-range Lennard–Jones and Coulomb interactions were 
calculated by a cutoff value of 14 Å, and the final MD pro-
duction was carried out with a time step of 2 fs for 50 ns in 
the NPT ensemble [46, 47]. The root-mean-square deviation 
(RMSD), root-mean-square fluctuation (RMSF), radius of 
gyration (Rg), solvent accessible surface area (SASA), and 
total intermolecular hydrogen bonds (H bonds) were calcu-
lated from MD simulations.
The binding free energy calculations
Molecular Mechanic/Poisson–Boltzmann surface Area 
(MM-PBSA) method [48] was used to calculate the binding 
free energy of the ligand–protein complex in the explicit 
solvent [49] using the g-mmpbsa script program [50]. The 
MD simulation trajectory of 50 ns was considered for the 
calculation of different components of the binding energy of 
the ligand and 3CLpro complex. The free energy of binding 
was calculated using the following equation:
Here, ΔGbind represent total binding free energy, while 
others show the free energy of ligand–protein complex, pro-
tein, and ligand, respectively.
the Ebonded , Evdw and Eele represent interactions among 
bonded, van der Waals, and electrostatic states. In contrast, 
the polar and nonpolar interactions to the solvation free 
energy are presented by the Gpolar and Gnonpolar , respectively, 
and -T∆S is the entropy contribution at temperature T.
Results and discussion
The main aim of this study was to identify potential cou-
marin phytochemicals as inhibitors for the 3CLpro pro-
tein of SARS-CoV-2. 3CLpro was selected because of its 
important role in viral replication. The molecular docking 
of all coumarin phytochemicals with 3CLpro was performed 
and the compounds that showed a strong binding affinity 
for 3CLpro were selected for further investigations. The 
ADMET properties of the top coumarin phytochemicals 
were analyzed and then, these compounds were evaluated 
through MD simulations and calculated free energy of bind-
ing for the compounds using MM-PBSA. This in silico study 
was undertaken to identify potential antiviral compound for 
COVID-19 (Fig. 1).
Molecular docking
The molecular docking approach to identify potential hits 
has become one of the most popular methods for structure-
based computer-aided drug discovery (SB-CADD). In this 
study, the molecular docking is done using MOE software 
ΔGbind = Gcomplex − Gprotein − Gligand





to find out the best candidates among the 50 coumarin phy-
tochemicals based on their binding scores. The results of the 
binding affinities from the docking analysis of the coumarin 
phytochemicals to 3CLpro of SARS-CoV-2 ranged from -5.0 
to -11.0 kcal/mol (Fig. 2).
The coumarin phytochemicals with more negative bind-
ing score values had higher binding affinities for 3CLpro 
and were ranked higher. The binding energy scores of the 
coumarin phytochemicals to 3CLpro of SARS-CoV-2, along 
with their binding energy scores to 3CLpro of SARS-CoV 
and MERS-CoV, are shown in Table S1.
As shown by Table S1, N3, lopinavir, and ritonavir that 
are considered as the co-crystal inhibitor of 3CLpro and ref-
erence inhibitors exhibited a docking score of − 10.92, − 6.84 
and − 10.89 kcal/mol for 3CLpro of SARS-CoV-2, whereas 
docking scores of N3, ritonavir, and lopinavir for 3CLpro 
of SARS-CoV equaled − 9.59  kcal/mol, − 8.10  kcal/
mol and − 9.97 kcal/mol and for 3CLpro of MERS-CoV 
equaled − 9.30 kcal/mol, − 8.17 kcal/mol and − 9.37 kcal/
mol. More than 50% of the coumarin phytochemicals 
showed docking score against SARS-coronavirus, which 
surpassed that of reference inhibitors.
The compounds glycycoumarin, Inophyllum P, oxypeu-
cedanin hydrate, and mesuol were found to exhibit 
the best docking scores of − 11.89, − 11.43, − 11.76, 
and − 11.17 kcal/mol, respectively, among the coumarin 
phytochemicals against 3CLpro of SARS-CoV-2, while gly-
cycoumarin had the highest binding affinity to that of SARS-
CoV and MERS-CoV (Table 1). Therefore, glycycoumarin 
was the top docked compound to 3CLpro that interacted 
strongly with the target protein of the coronavirus. Analy-
sis of the interactions of the best coumarin phytochemicals 
and reference inhibitors with amino acid residues of 3CLpro 
of coronaviruses (Table 1) showed that these compounds 
majorly interacted with the hotspot residues through hydro-
phobic interactions and with H-bonding under 4.0 Å (par-
ticularly with Cys145 and His41).
The results of the molecular docking of the best coumarin 
phytochemicals including glycycoumarin, Inophyllum P, 
mesuol, oxypeucedanin hydrate and reference inhibitors in 
the active site of SARS-CoV-2 3CLpro illustrated by their 
corresponding 2D interaction plots that the selected com-
pounds interacted with either both (Cys145 and His41) or 
at least one catalytic dyad residue, detected by MOE (Fig. 3 
and Fig. S5) [1, 18, 32, 43, 51]. The selected compounds and 
Ritonavir and lopinavir exhibit similar binding modes due 
to the parallel orientations of the ligands and their same key 
residues (Fig. 3), such as His41, Met49, Phe140, Leu141, 
Asn142, Gly143, Ser144, Cys145, Met165, His164, Glu166, 
Gln189, and Thr190. The results of ligand–protein binding 
interaction showed that ritonavir and lopinavir as reference 
inhibitors were docked into the active site and catalytic dyad 
(Cys145 and His41) of SARS-CoV-2. Ritonavir could form 
two hydrogen bonds with the side chain of Thr25 and the 
backbone of Glu166 (Fig. 3a), while lopinavir with a con-
siderably higher binding energy (− 10.890 kcal/mol) than 
Ritonavir showed significant π-π stacking interaction with 
His41 of the catalytic dyad and form one hydrogen bond 
with the side chain of Gln189 (Table 1, Fig. 3b) and also, 
both of the inhibitors had hydrophobic interactions with 












Fig. 1  Schematic representation of various steps of the methodology 

























Fig. 2  Frequency distribution of 50 coumarin phytochemicals over 
the range of docking scores
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agent known to inhibit hepatitis C virus (HCV) [29] and 
giant cell formation in HIV [30, 52], had significant bind-
ing to the catalytic dyad of SARS-Cov-2 that interacted 
with His41 by π-π stacking interaction and form hydrogen 
bonds with the backbone of Cys145 and also side chain of 
Ser144 and Gln189 along with hydrophobic interactions 
with the other residues such as Met49, Met165, Leu141 and 
Phe140 (Table 1, Fig. 3c). Inophyllum P, as an anti-viral 
used to inhibit HIV-1 reverse transcriptase [30], was stabi-
lized through hydrogen bonding with the catalytic residue 
of Cys145, the backbone of Leu141 and the side chain of 
Ser144, π-π stacking interaction with the catalytic residue 
of His41, and hydrophobic interactions with the other sur-
rounding residues (Fig. 3d). Mesuol, as simple coumarin that 
suppresses HIV-1 replication in Jurkat T cells [53], formed 
one hydrogen bond with the catalytic residue of Cys145 
and two hydrogen bonds with the side chain of Asn142 and 
Ser144 and also, the other interactions with neighboring 
residues (Fig. 3e). Oxypeucedanin hydrate, a furanocou-
marin reported to have anti-HIV effects [26, 54], stabilized 
the active site of 3CLpro of SARS-CoV-2 through hydro-
gen bonding interactions with the catalytic residue of the 
catalytic dyad (Cys145) and Ser144, His163, His164 and 
Gln189, π-π stacking interaction with the catalytic residue 
Table 1  Interacting amino acid (aa) residues of 3CLpro of coronaviruses with the best coumarin phytochemicals
Bioactive compound Coronavirus Interacted residues aa residue involved in H-bonding (Bond Distance)
Ritonavir SARS-CoV-2 His 41, Cys145, Gly143, Met165, His164, 
Glu166, Asn142, Met49, Gln189, Thr26, Thr24, 
Thr25, Thr45, Ser46
Glu166 (2.48), Thr25 (3.72)
Lopinavir His 41, Cys145, Gly143, Met165, His164, 
Glu166, Asn142, Leu141, Phe140, Met49, 
Gln189, Asp187
Gln189 (2.08)
Glycycoumarin His 41, Cys145, Ser144, Gly143, Met165, His164, 
Glu166, Asn142, Leu141, Phe140, Met49, 
Gln189, Asp187, Arg188, Tyr54
Cys145 (2.46), Ser144 (1.91), Gln189 (2.15)
Inophyllum P His 41, Cys145, Ser144, Gly143, Met165, His164, 
Glu166, Asn142, Leu141, Phe140, Met49, 
Gln189, Leu27
Cys145 (2.607), Ser144 (2.23), Leu141 (3.18)
Mesuol His 41, Cys145, Ser144, Gly143, Met165, His164, 
Glu166, Asn142, Leu141, Phe140, Met49, 
Gln189, Ser46
Cys145 (2.608), Ser144 (3.77), Asn142 (1.27)
Oxypeucedanin hydrate His 41, Cys145, Ser144, Gly143, Met165, His164, 
Glu166, Asn142, Leu141, Phe140, Met49, 
Gln189, His163, Thr25, Thr26, Leu27
Cys145 (3.04), Ser144 (2.21), His163 (2.86), 
His164 (3.04)
Glycycoumarin SARS-CoV Gln189, Met165, His164, Cys145, His41, Arg188, 
Asp48, Cys44, Thr25, Glu47, Thr24, Thr45, 
Ala46
His164 (2.41), Cys44 (2.51), Thr24 (2.30)
Inophyllum G2 Gln189, Met165, His164, Cys145, His41, Arg188, 
Asp48, Cys44, Glu47, His163, Glu166, Met49, 
Asn142, Leu27, Thr26
His164 (2.862), Glu166 (3.09), Asn142 (2.47)
licopyranocoumarin Phe140, Met165, His164, Cys145, His41, Ser144, 
Asp48, Cys44, Glu47, His163, Glu166, Met49, 
Asn142, Leu25, Thr24, Asp48, His172
His163 (2.35), Thr25 (2.29, thr45 (3.72)
Wedelolactone Phe140, Met165, His164, Cys145, His41, Ser144, 
Asp48, Glu47, His163, Glu166, Met49, Asn142, 
His172, Leu141, Gly143
Glu166 (2.07), Ser144 (1.72), Leu141 (2.02)
Glycycoumarin MERS-CoV Met6, Asp294, Gln299, Asp295, Met298, Asn156, 
Glu157, Glu155
Met6 (2.21), Asp295 (2.16), Asn156 (1.93)
licopyranocoumarin Met6, Asp294, Gln299, Asp295, Met298, Asn156, 
Glu157, Glu155, Thr13, Lys5, Phe291, Ala8, 
Ser7,
Gln299 (1.790), Asn156 (3.58), Gly157 (3.21)
Wedelolactone Met6, Asp294, Gln299, Asp295, Met298, Asn156, 
Glu157, Glu155, Thr130, Phe291, Ala8, 
Phe115, Ser116, Thr154,
Glu155 (2.56), ser116 (2.48), Thr130 (3.22), 
Asp295 (2.84)
Isomesuol Met6, Asp294, Gln299, Asp295, Met298, Asn156, 
Glu157, Glu155, Ala8, Thr154, Ser116, Tyr153, 
Phe115, Phe291





His41 and hydrophobic interactions with surrounding amino 
acid residues (Fig. 3f). The carbonyl oxygen of the coumarin 
ring mediated the three hydrogen bonds with the backbone 
of Cys145 and the side chain of Ser144 and His163. The 
side chain of Gln189 and backbone of his164 established 
hydrogen bonds with different hydroxyl groups.
Like the ligand–protein binding interaction of glycycou-
marin to SARS-CoV-2 3CLpro that targeted the Cys-His cat-
alytic dyad (Cys145 and His41) along with the other binding 
residues, the docking analysis showed that the SARS-CoV 
3CLpro interacted with the same ligand differently. Glycy-
coumarin interacted with His41 in catalytic dyad and Cys44 
and Asp48 by hydrogen bonding interactions (Fig. 4a). For 
licopyranocoumarin, hydrogen bonding interactions with 
His164 and Glu166 were observed and it further interacted 
with His41 via π-π stacking interaction (Fig. 4b). The inter-
action of Inophyllum G2 with SARS-CoV3CLpro showed 
a hydrogen bonding to His164 and Glu166 while π-π stack-
ing interaction was observed between His41 and ligand 
(Fig. 4c). His41, Ser144, and Glu166 residues of the pro-
tein interacted with wedelolactone via hydrogen bonds while 
His41 interacted via π-π stacking interaction to wedelolac-
tone (Fig. 4d). These residues in the active site of SARS-
CoV 3CLpro were also conserved for the Cys-His catalytic 
dyad binding hotspot.
Glycycoumarin, licopyranocoumarin, wedelolactone, and 
isomesuol interacted with MERS-CoV 3CLpro that is dif-
ferent from the other two coronaviruses. Hydrogen bonds 
were observed between glycycoumarin/isomesuol/wedelo-
lactone and Asp295 while extra hydrogen bonds were also 
observed for glycycoumarin with Met6 and Asn156, wedelo-
lactone with Glu155, Ser116 and Thr130, and isomesuol 
with Glu155 while licopyranocoumarin interacted via hydro-
gen bonding interactions to Gly157, Asn156 and Gln299. 
In addition to this, the other residues (Val4, Ala8, Thr154, 
Phe291, Asp294, and Met298) are involved in forming 
hydrophobic interactions with these compounds (Table1 
and Fig. 5a-d).
The results of this study showed that 8 compounds 
(glycycoumarin, Inophyllum P, mesuol, oxypeucedanin 
hydrate, glycycoumarin, Inophyllum G2, licopyranocou-
marin, wedelolactone) with a considerable inhibitory ten-
dency towards the SARS-coronavirus were identified from 
coumarin phytochemicals. All of the compounds such as 
glycycoumarin, Inophyllum P, mesuol, and oxypeucedanin 
hydrate were docked into the active site and were interacting 
with the catalytic dyad (Cys-His) of 3CLpro protein of the 
coronaviruses in a similar pattern as ritonavir and lopinavir 
(Fig. 3).
ADMET properties and drug likeness
In the next step, we employed pkCSM online-server 
(http:// biosig. unime lb. edu. au/ pkcsm/ predi ction) for pre-
dicting the ADMET features of the selected compounds 
and applied the Lipinski’s rule of five to screen the cou-
marin phytochemicals and filtered the orally bioavailable 
compounds. After that, we assessed the synthetic avail-
ability of the coumarin derivatives by the Swiss ADME 
online-tool (http:// www. swiss adme. ch/ index. php). Its scale 
demonstrated a score of 1 for a relatively simple synthetic 
route, whereas a score closer to 10 had a high structural 
complexity, and was therefore difficult to synthesize.
According to the studies [55, 56], water solubil-
ity has been considered to be crucial to approximate 
the absorption of the medicines in the body, which has 
been given in the log (mol/L) ( insoluble < -10 < poorly 
soluble < -6 < moderately < -4 < soluble < -2 < very solu-
ble < 0 < highly soluble). The intestinal absorption of 
all the selected compounds (88.20–97.44%) revealed an 
acceptable absorption feature. Furthermore, the blood/
brain partition coefficient (log BB) of the top compounds 
indicated a lower opportunity for crossing the blood–brain 
barrier (BBB). Results have also shown that steady-state 
volume of distribution (VDss, log L/kg) value of glycycou-
marin has been <  − 0.15, which reflects more distribution 
of the above compound in the plasma rather than in the 
tissues whereas Inophyllum P, oxypeucedanin hydrate, and 
mesuol showed more distribution in the tissues (Table 3). 
For metabolism, two compounds mesuol and Inophyllum 
P were predicted as the substrate for the CYP450 3A4 
subtype, also these compounds might be metabolized by 
CYP2D6. At the same time, the selected compounds could 
not inhibit the CYP450 2D6 subtype; however, compounds 
like mesuol, Inophyllum P and glycycoumarin might 
inhibit 2C6, 2C19, as well as CYP450 3A4 subtypes and 
all the selected compounds, could inhibit CYP450 1A2 
subtype. Based on the prediction of the total clearance, 
hepatic and renal tissue can be used to clear such phyto-
chemicals. The expected toxicity represents the fact that 
each compound did not show any skin sensitization and 
has been not detrimental to the liver. Moreover, Ames test 
has been used to reveal the anticipated toxicity, reflect-
ing that oxypeucedanin hydrate has been not mutagenic. 
Additionally, the synthetic accessibility score of the 
selected phytochemicals equaled 3.55–5.12. With regard 
to Tables 2 and 3, bioavailability and ADMET (Rule of 
Five, Veber, Ghose, Muegge, & Egan) are in the reason-
able ranges for the selected phytochemicals in solubility 
and lipophilicity. According to each parameter, it is pos-
sible to employ coumarin phytochemicals as the antiviral 
agents to treat COVID-19.
Fig. 3  2D view of the binding conformation of ligands in binding 
pocket of SARS-CoV-2 3CLpro, a Ritonavir, b Lopinavir, c Glycy-




PASS prediction for antiviral activity
Studies have also considered PASS as a popular tool 
employed in nearly every drug industry with regard to 
the analyses of the structure–activity relationship [57]. It 
gives the prediction score for biological activities on the 
ratio of probability to be active (Pa) and probability to 
be inactive (Pi). A higher Pa means the biological activ-
ity is having more probability for a compound. Moreover, 
researchers identified the biological activity spectra of top 
coumarin chemicals which are deposited [58] in the PASS 
database. Table 4 presents the prediction results of ten 
biological activities for the top scoring coumarins. Nota-
bly, the present research results indicated the major utility 
of the PASS plan to predict the biological activities of a 
coumarin-phytochemical based on the respective coumarin 
structure that has been shown by an average prediction coef-
ficient equal to 0.85 (Pa ranging from 0.243 to 0.937 when 
Pa > Pi) for the selected 4 compounds. Besides, the results 
revealed a number of biological activities of the selected 
compounds amongst the ten experimented activities. How-
ever, as shown in Table 5, for several instances PASS was 
unable to provide predictions for some of the biological 
activities.
Table 5 reports probable sites of metabolism (SOM) 
through CYPs 1A2, 2B6, 2A6, 2C8, 2C19, 2E1, 3A4 and 
2D6 of glycycoumarin, oxypeucedanin hydrate, Inophyl-
lum P and mesoul. Probable sites of a chemical compound, 
wherein the metabolism by the isoforms of CYP450 
enzymes happen, are marked by circles on the molecule’s 
Fig. 4  2D representation of 3CLpro amino acid interactions of SARS-CoV with coumarin phytochemicals; a glycycoumarin, b licopyranocou-
marin, c Inophyllum G2, d wedelolactone
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chemical structure [37]. According to P450 SOM predic-
tion, glycycoumarin possessed 4 sites for CYP 450 2A6, 
CYP 450 1A2, CYP 450 2C19, CYP 450 2B6, CYP 450 
2D6, CYP 450 2C8, CYP 450 3A4 and CYP 450 2E1. 
Oxypeucedanin hydrate had 5 sites of metabolism (SOMs) 
for the CYP 450 2C19 enzyme, 4 sites for CYP 450 1A2, 
2A6, 2B6, 2C8, and 2D6, 3 sites for CYP 450 2C9, 2E1, 
and 3A4. The P450 SOM predictions for Inophyllum P 
showed 4 sites of SOMs for the CYP 450 1A2, 2C8, 2C9, 
2C19, 2D6, and 3A4 and 3 sites for CYP 450 2A6, 2B6, 
and 2E1. Mesoul had 4 sites of SOMs for the CYP 450 
2A6, and 3 sites for the CYP 450 1A2, 2B6, 2C8, 2C9, 
2C19, 2D6, 2E1, and 3A4.
Fig. 5  2D representation of 3CLpro amino acid interactions of MERS-CoV with coumarin phytochemicals; a Glycycoumarin, b Licopyranocou-




Molecular target studies are important to find the pheno-
typic side effects or potential cross reactivity caused by the 
action of glycycoumarin, oxypeucedanin hydrate, Inophyl-
lum P, and mesuol as the best coumarin compounds. Fig-
ure 6 shows the % bioactivity of the top coumarins with 
respect to selected protein targets viz. enzymes, kinases, 
oxidoreductases, proteases, Family A G protein-coupled 
receptor, phosphodiesterases, and lyases as a pie-chart. Anal-
ysis revealed that proteases, Family A G protein-coupled 
receptors, and kinases were the main predicted targets for 
all the proposed compounds. The pie chart of the glycy-
coumarin predicted 32% of Kinase, 4% of Protease, 4% of 
Phosphatase, 4% of Hydrolase, 12% of Cytochrome P450, 
8% of Enzyme (including: Estradiol 17-betadehydrogenase2, 
Dynamin-1, N-acylsphingosineamidohydrolase, Phospholi-
pase A2, Aldo–keto reductase family 1 member B10), 8% 
of Oxidoreductase, 12% of Nuclear receptors, 4% of Elec-
trochemical transporters, 4% of Phosphodiesterase, 4% of 
Unclassified protein and 4% of Family A G protein-coupled 
receptor. The possible sites of the target which the glycycou-
marin may bind were Kinase, Cytochrome P450 and Nuclear 
receptors which stimulate the drug reaction accordingly. 
Also, this analysis presents an explanation for the use of 
glycycoumarin, oxypeucedanin hydrate, Inophyllum P, and 
Mesuol as SARS-CoV-2 main protease inhibitors.
Pharmacophore mapping
We implemented pharmacophore mapping for glycycou-
marin that including two hydrogen-bond acceptor features, 
three hydrogen-bond donor and acceptor features and two 
aromatic ring features. Moreover, it created an acceptable 
number of significant contacts with 3CLpro pharmacophore 
(Fig. 7) and the features of the glycycoumarin compound 
Table 2  Drug likeness 
properties of the top binding 
coumarin phytochemicals
The general recommended ranges are as follows:
a Molecular weight, < 500
b Predictedoctanol/water partition coefficient, − 0.4 to + 5.6
c Predicted aqueous solubility, < -5.0
d Number of hydrogen bond acceptors, < 10
e Number of hydrogen bond donor, < 5
f Rotatable bonds, < 10
g Polar surface area, < 140 A°2
h Pan-Assay Interference
j Structural Alert
Drug Likeness Properties Glycycoumarin Inophyllum P Mesuol Oxypeu-
cedanin 
hydrate
Molecular weight (g/mol)a 368.38 404.46 392.44 304.29
Consensus Log Po/wb 3.54 4.14 4.56 1.79
Log  Sc  − 5.06  − 5.28  − 5.87  − 2.69
Num. H-bond  acceptord 6 5 5 6
Num. H-bond  donore 3 1 2 2
No of Rotatable  Bondsf 4 1 5 4
Molar Refractivity 104.20 116.97 115.49 80.34
Lipinski Yes Yes Yes Yes
Ghose Yes Yes Yes Yes
Veber Yes Yes Yes Yes
Egan Yes Yes Yes Yes
Muegge Yes Yes No Yes
Bioavailability score 0.55 0.55 0.55 0.55
TPSA  (A2)g 100.13 68.90 87.74 93.04
Synthetic accessibility (SA) 3.55 5.12 3.88 3.79
Solubility (mol/l) 1.79e-06 5.20e06 1.36e06 2.05e03
PAINSh 0 alert 0 alert 0 alert 0 alert
Brenkj 2 alert 1 alert 2 alert 1 alert
Leadlikeness No No No Yes
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were found to directly correspond to some key amino acids 
including His41, Gly143, Cys145, Asn142, Ser144, Glu166, 
Gln189, and His164, which play a critical role in 3CLpro 
inhibition activity. As shown in Fig. 7, the hydroxyl groups 
of the glycycoumarin that formed multiple direct hydrogen 
bond interactions with Asn142, His164 and Glu166 mapped 
the F3-F5 features. The methoxy group of the glycycoumarin 
showing a hydrogen bond interaction with Gln189 overlaid 
the F2 feature, while the carbonyl group that enabled con-
siderable interactions with Cys145 and Ser144 mapped the 
F1 feature. Moreover, the benzene rings of the glycycou-
marin that formed hydrophobic interactions with His41 and 
Phe140 mapped the F6-F7 features.
Molecular dynamics simulation study
Molecular dynamics (MD) simulation is an imperative 
method to explore the conformational stability of virtual 
complexes and the contribution of key amino acid residues 
in ligand binding. The MD simulations for 3CLpro-glycy-
coumarin, 3CLpro-oxypeucedaninhydrate, and 3CLpro-
Inophyllum P complexes along with that of three other 
systems (ligand free 3CLpro, 3CLpro-N3, and 3CLpro-
lopinavir) were done for 50 ns to analyze the stability of 
these docked phytochemical compounds and evaluate the 
possible binding modes of the ligands. As depicted in Fig. 8, 
the backbone RMSD value of ligand free 3CLpro increased 
gradually until ~ 3.32 Å (0–5 ns), and then the RMSD value 
from 5 to 34 ns maintained a constant value (~ 2.77–2.88 Å). 
The value increased from 34 to 43 ns (~ 3.88–3.86 Å) and 
then decreased and reached 3.40 Å and remained almost 
the same till the end of the MD simulation. The RMSD 
value of the 3CLpro-N3 complex was ~ 3.22 Å at 22.50 ns, 
which rose to ~ 3.42 Å at 23.50 ns and persisted at the same 
value till 50 ns. The RMSD value for 3CLpro-lopinavir 
was found to remain almost constant (~ 3.84–4.04 Å) from 
15 to 50 ns with some marginal fluctuations. The RMSD 
value of the 3CLpro-glycycoumarin complex increased 
from ~ 3.22 Å (at 2 ns) up to ~ 3.54 Å (at 22.50 ns). Then, 
within the next 10 ns, the value was decreased (~ 2.62 Å) 
and then, increased gradually until 3.65 Å and remained 
almost constant till the end of the MD run with some mar-
ginal fluctuations. For the 3CLpro-oxypeucedaninhydrate, 
the RMSD value increased gradually and reached to ~ 3.66 Å 
at 15 ns. Then, the RMSD value slightly decreased and per-
sisted at ~ 3.20 Å from 18.30 ns till the end of the MD run. 
For 3CLpro-Inophyllum P, the RMSD value was found 
to remain almost constant (~ 3.28–3.46 Å) from 5.0 ns to 
50.0 ns with some marginal fluctuations. The average RMSD 
values for ligand free 3CLpro, 3CLpro-N3 and 3CLpro-
lopinavir systems were found to be 2.89 Å, 3.33 Å, and 
3.78 Å, respectively, whereas the average RMSD values of 





































































































































































































































































































































































3CLpro-Inophyllum P complexes were 3.12 Å, 3.18 Å, and 
3.37 Å, respectively. RMSD results showed that these three 
complexes were stable and the stability of 3CLpro-glycy-
coumarin was highest among all of them. Also, 3CLpro-
coumarin complexes were more stable than the 3CLpro-
lopinavir complex. In RMSD of 3CLpro with N3, lopinavir, 
glycycoumarin, oxypeucedanin hydrate, and Inophyllum P, 
the change was slightly more than ligand free 3CLpro that 
seemed that binding of the ligand with 3CLpro increased the 
conformational flexibility of 3CLpro.
The RMSF could be used to understand fluctuations as 
well as the flexibility of each residue in the different regions 
of simulated proteins. The average values of RMSF for 
ligand free 3CLpro, 3CLpro-N3, and 3CLpro-lopinavir 
were 1.85 Å, 1.80 Å, and 1.81 Å, respectively (Fig. 9). In 
ligand free 3CLpro system, most of the amino acid residues 
within the domain I and II of this system had RMSF fluctua-
tion below 3.0 Å and only, residues 72, 155, and 168–170 
showed higher fluctuations (up to 3.0 Å). The RMSF plot 
in Fig. 9 showed that 3CLpro-N3 and 3CLpro-lopinavir 
suffer more conformational fluctuations in domain III. The 
RMSF plot of the 3CLpro-N3 complex showed that very 
few amino acid residues within domain I, II, and III (resi-
dues 155, 215–217, 221–223, 274, and 278) have an RMSF 
value of more than 3.0 Å. The RMSF plot of 3CLpro-lopi-
navir showed more or less similar conformational fluctua-
tions that of the ligand free 3CLpro system. The fluctua-
tions for many amino acid residues of domain I and II were 
reduced upon the binding of lopinavir to 3Clpro. Also, the 
RMSF plot in Fig. 9 showed that 3CLpro-N3 and 3CLpro-
lopinavir complexes suffer more conformational fluctua-
tions in domain III. Analysis of RMSF plots showed that 
3CLpro-glycycoumarin, 3CLpro-oxypeucedanin hydrate 
and 3CLpro-Inophyllum P complexes had similar trends 
of dynamic fluctuation and RMSF distributions with aver-
age values of 1.78 Å, 1.78 Å and, 1.79 Å. These values 
indicated that 3CLpro-glycycoumarin, 3CLpro-oxypeuce-
danin hydrate and 3CLpro-Inophyllum P complexes showed 
lower conformational fluctuation as compared to ligand free 
3CLpro and 3CLpro-N3/lopinavir complexes. The fluctua-
tion of various specific amino acid residues (Thr25, Thr26, 
His41, and Met49 in domain I; Phe140, Leu141, Asn142, 
Gly143, Ser144, Cys145, His163, His164, and Glu166 of 
domain II and Gln189 and Thr190 of domain III) in 3CLpro-
coumarin complexes was less than that in ligand free 3CLpro 
and 3CLpro-N3/lopinavir complexes indicating that these 
residues within the binding pocket of 3CLpro protein inter-
acted with these three coumarins while the loop regions and 
the C-terminal and N-terminal of the protein were largely 
fluctuating in all systems. His41 and Cys145 residues of the 
catalytic dyad in SARS-CoV-2 3CLpro showed RMSF of 
1.48 Å and 1.30 Å, respectively. The His41 residue showed 
RMSF of 1.40 Å and 1.46 Å for 3CLpro-N3/lopinavir com-
plexes, respectively, whereas in 3CLpro-glycycoumarin, 
3CLpro-oxypeucedanin hydrate and 3CLpro-Inophyllum P 
complexes His41 exhibited the RMSF of 1.28 Å, 1.31 Å, 
and 1.36 Å, respectively. The Cys145 residue exhibited the 
RMSF of 1.22 Å, 1.27 Å, 0.94 Å, 1.10 Å, and 1.19 Å for 
N3, lopinavir, glycycoumarin, oxypeucedanin hydrate, and 
Inophyllum P-protein systems, respectively, indicating the 
stability of the target protein with smaller conformational 
changes and the lower fluctuations in binding residues of 
catalytic dyad for all three 3CLpro-coumarin complexes than 
that of the 3CLpro-N3/lopinavir complex.
RMSD and RMSF analysis revealed that the SARS-
CoV-2 3CLpro-glycycoumarin docking complex was highly 
stable during 50 ns simulations. Hydrogen bonding plays a 
significant role in determining the stability of a ligand–pro-
tein complex. The average numbers of intermolecular hydro-
gen bonds for ligand free 3CLpro, 3CLpro-N3, and 3CLpro-
lopinavir were 481, 503, and 489, respectively, whereas the 
average numbers of intermolecular hydrogen bonds for 
Table 4  The PASS prediction 
results of the biological 
activities of the coumarin 
phytochemicals series
Pa: prediction of activity spectra for substances; Pi: probable inactivity
No Biological activities Glycycoumarin Inophyllum P Mesuol Oxypeuceda-
nin hydrate
Pa Pi Pa Pi Pa Pi Pa Pi
1 Membrane integrity agonist 0.937 0.002 – – 0.683 0.058 0.720 0.051
2 HMOX1 expression enhancer 0.635 0.015 – – 0.265 0.115 0.355 0.072
3 Chlordeconereductase inhibitor 0.803 0.02 – – 0.243 0.193 0.344 0.132
4 HIF1A expression inhibitor 0.936 0.004 0.867 0.008 0.348 0.135 0.512 0.053
5 Histidine kinase inhibitor 0.709 0.008 0.765 0.005 0.467 0.035 0.498 0.029
6 Aldehyde oxidase inhibitor 0.807 0.009 – – – – 0.654 0.023
7 Antimutagenic 0.877 0.003 – – – – 0.735 0.005
8 Mucomembranous protector 0.648 0.081 – – 0.307 0.234 – –
9 TP53 expression enhancer 0.901 0.005 0.484 0.098 0.616 0.045 0.580 0.056
10 Chemopreventive 0.807 0.004 0.665 0.008 0.615 0.009 0.596 0.010
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Table 5  List of the P450 sites 
of metabolism prediction 
study of the Glycycoumarin, 
Oxypeucedanin hydrate 



















3CLpro-glycycoumarin, 3CLpro-oxypeucedanin hydrate, 
and 3CLpro-Inophyllum P complexes were found to be 494, 
516, and 502, respectively (Fig. 10). The highest number of 
hydrogen bonds was observed for 3CLpro-oxypeucedanin 
hydrate, while the lowest number of hydrogen bonds was 
observed in ligand free over the 50 ns simulations. 3CLpro-
ligand complexes possessed a greater number of hydrogen 
bonds compared to ligand free 3CLpro which these hydro-
gen bonds stabilized the protein–ligand complexes during 
simulation.
Analysis of the main protease-ligand complexes revealed 
most of the compounds form Hydrogen bonds with the 
amino acid residues of the binding pocket (Fig. 11). In the 
3CLpro-N3 complex, the majority of conformations formed 
up to 3 hydrogen bonds during the MD simulation and a 
small number of conformations exhibited less than 1 and 
greater than 6 hydrogen bonds. For the 3CLpro-lopinavir 
complex, lopinavir formed 1 to 2 hydrogen bonds with 
residues of the binding pocket. In 3CLpro-oxypeucedanin 
hydrate and 3CLpro-Inophyllum P complexes, the num-
ber of hydrogen bonds formed was between 2 and 5 in the 
whole simulation while 3CLpro-glycycoumarin complex 
showed changes in bonding. More hydrogen bonds (> 5) 
were between 0 and 13 ns, after 13 ns the hydrogen bonds 
decreased to less than 5, and the last 15 ns, the hydrogen 
bond was between 2 and 4. This might suggest that there was 
a conformational change around glycycoumarin in the bind-
ing site during simulation. Overall, the results showed that 
all three 3CLpro-coumarin complexes were highly stable.
The radius of gyration (Rg) parameter is used to describe 
the compactness and rigidity of the ligand–protein complex 
during MD simulation, in which less compactness (more 
unfolded) depicts a higher Rg value with conformational 
entropy, while low Rg values explain strong compactness 
and higher structural stiffness (more folded). As shown in 
Fig. 12, average Rg values of 3CLpro-N3 complex (21.13 Å) 
Fig. 6  Top-25 of target predicted for a Glycycoumarin, b Oxypeucedanin hydrate, c Inophyllum P and d Mesuol
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Fig. 7  Pharmacophore Mapping of glycycoumarin in the binding site of 3CLpro. Cyan color-hydrogen bond acceptor, orange color-aromatic, 
dark pink color- hydrogen bond acceptor and donor
Fig. 8  RMSD plots of ligand 
free 3CLpro, 3CLpro-N3, 
3CLpro-lopinavir, 3CLpro-gly-
cycoumarin, 3CLpro-oxypeu-
cedanin hydrate, and 3CLpro-

























Fig. 9  RMSF plot of ligand free 



























and 3CLpro-lopinavir complex (21.18 Å) were found to be in 
a similar range with ligand free 3CLpro (21.14 Å). The aver-
age Rg value for 3CLpro-glycycoumarin (21.03 Å), 3CLpro-
oxypeucedanin hydrate (21.09 Å), and 3Clpro-Inophyllum 
P (21.13 Å) systems was slightly lower than that of the 
other three systems (ligand free 3CLpro, 3CLpro-N3, and 
3CLpro-lopinavir). In an argument with the above observa-
tion, these molecules did not induce structural changes and 
were relatively more rigid than the N3, lopinavir, and ligand 
free 3CLpro and all three 3CLpro-coumarin complexes were 
Fig. 10  Total number of H-bond 
count throughout the simulation 
for ligand free 3CLpro and the 




























Fig. 11  Number of intermo-
lecular hydrogen bonds between 
3CLpro of SARS-CoV-2 and 
N3, glycycoumarin, oxypeu-































Fig. 12  Radius of gyration (Rg) 
plot ligand free 3CLpro and the 





















compact throughout the simulation, indicating that the com-
plexes were well converged.
Solvent Accessible Surface Area (SASA) value indicates 
the degree of expansion of protein volume in each system 
over the simulation time. The average SASA values of the 
3CLpro-N3 complex (~ 17,501.49 Å2) and the 3CLpro-
lopinavir complex (~ 17,578.51 Å2) were higher than the 
three 3CLpro-coumarin complexes suggesting an expansion 
of 3CLpro during the interaction with N3 and lopinavir. The 
average SASA values of 3CLpro-glycycoumarin, 3CLpro-
oxypeucedanin hydrate, and 3CLpro-Inophyllum P com-
plexes were 17,264.84 Å2, 17,377.37 Å2, and 17,487.35 Å2, 
respectively. These values indicated that all three 3CLpro-
coumarin complexes were slightly lower than that of the 
ligand free 3CLpro (17,578.51 Å2) and 3Clpro-N3/lopina-
vir (Fig. 13), suggesting that the binding of glycycoumarin, 
oxypeucedanin hydrate, and Inophyllum P potentially could 
reduce 3CLpro protein expansion.
MM‑PBSA binding free energy calculation
The binding free energy of the ligand–protein complex was 
performed to revalidate the ligand affinity to the target recep-
tor for the ligand–protein complex predicted by the molecu-
lar docking studies. The MM-PBSA free energy values of 
the 3CLpro-glycycoumarin, 3CLpro-oxypeucedanin hydrate 
and 3CLpro-Inophyllum P complexes, as well as 3CLpro-
N3 and 3CLpro-lopinavir, were calculated from 50 ns tra-
jectories corresponding to every 5 ns time interval. Each 
energy term, including van der Waals energy, electrostatic 
energy, polar solvation energy, solvent accessible surface 
area (SASA) energy, and total binding free energy of the 
systems was given in Table 6. The calculated ΔG binding 
energy values of 3CLpro-N3 and 3CLpro-lopinavir com-
plexes were found to be -56.25 kJ/mol and -40.94 kJ/mol 
(Table 6). On the contrary, the binding free energy values 
of 3CLpro-glycycoumarin, 3CLpro-oxypeucedanin hydrate, 
and 3CLpro-Inophyllum P complexes were − 60.31 kJ/mol, 
-58.86 kJ/mol and − 57.75 kJ/mol and these negative val-
ues of ΔG binding energy indicated that the selected com-
pounds favorably interact with the target protein of 3CLpro. 
Among all the 3CLpro-coumarin complexes, the 3CLpro-
glycycoumarin complex exhibited the highest binding free 
energy, while the 3CLpro-Inophyllum P complex showed 
the lowest binding free energy. According to the results of 
Table 6, the major favorable contributors were van der Waals 
(ΔEvdW) and electrostatic (ΔEelec) interactions and SASA 
energy while the polar component of solvation (ΔG polar) 
contributed unfavorably to the binding of glycycoumarin, 
oxypeucedanin hydrate, and Inophyllum P to 3CLpro and the 
Fig. 13  Solvent accessible 
surface area (SASA) plot ligand 
free 3CLpro and the 3CLpro-





















Table 6  Binding free energy for glycycoumarin, oxypeucedanin hydrate and Inophyllum P and 3CLpro of SARS-CoV-2 calculated by MM-
PBSA analysis











3CLpro-N3  − 51.67  − 45.39 54.58  − 13.77  − 56.25
3CLpro-Lopinavir  − 33.24  − 38.83 43.76  − 12.63  − 40.94
3CLpro-glycycoumarin  − 44.16  − 58.58 58.59  − 16.15  − 60.31
3CLpro-Oxypeucedanin hydrate  − 48.97  − 53.79 63.13  − 19.23  − 58.86
3CLpro-Inophyllum P  − 53.48  − 45.78 56.49  − 14.97  − 57.75
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selected coumarin phytochemicals may inhibit the SARS-
CoV-2 main protease.
For determining the key residues involved in the ligand 
activities as well as understanding the interactions of the 
ligand with the 3CLpro protein residues, total binding free 
energy decomposed into the contribution energy of diverse 
residues at the active site of 3CLpro protein with all the 
five ligands has been computed and showed that the most 
contributive residues were Met49, His41, Gly143, Asn142, 
Cys145, Ser144, Glu166, Gln189, and Met165. Figure 14 
depicts the respective energy contribution. These findings 
agree with, and mutually support, previously reported results 
of the main interacting residues within the 3CLpro active 
site that are deemed critical for effective ligand binding [59, 
60].
The results indicated that catalytic dyad (His41 and 
Cys145) in the 3CLpro-coumarin complexes had a major 
energy contribution in binding affinity of 3CLpro compared 
to that of the 3CLpro-N3/lopinavir complexes. From Fig. 14, 
it was found that interactions of Cys 145 (− 9.18, − 9.21 
and − 8.92 kJ/mol) by hydrogen bonds with glycycoumarin, 
oxypeucedanin hydrate, and Inophyllum P compounds had 
the biggest energy contribution to these complexes; and 
Asn142 (− 7.81, − 5.77 and − 5.27 kJ/mol) was also found to 
be one of the most important residues for activity by hydro-
gen bonds with glycycoumarin, oxypeucedanin hydrate, and 
Inophyllum P compounds, respectively. Whereas the bind-
ing free energy values of Cys145 and Asn142 residues in 
the 3CLpro-N3 complex were − 6.85 kJ/mol and − 3.68 kJ/
mol and for 3CLpro-lopinavir complex were found to 
be − 3.36 kJ/mol and − 1.30 kJ/mol, respectively. Ser144 
residue made a significant contribution with glycycoumarin, 
oxypeucedanin hydrate, and Inophyllum P through hydrogen 
bond with − 5.28 kJ/mol, − 6.52 kJ/mol and − 5.76 kJ/mol 
values of the binding free energy. Also, Gly143, Glu166, and 
Gln189 contributed significantly to the interaction energy 
with glycycoumarin, oxypeucedanin hydrate, and Inophyl-
lum P by hydrogen bond formation with these compounds; 
hence the contributions of Gly143, Glu166 and Gln189 
were advantageous for affinity binding. His41, Met49, and 
Met165 could have hydrophobic interactions as well as 
π − π stacking with the selected coumarin phytochemicals 
and make significant positive contributions to the binding of 
ligands with 3CLpro. In addition to the catalytic dyad, key 
residues of Asn142, Gly143, Glu166, and Gln189 favorably 
contribute to the binding affinity and verify the reliability of 
the molecular docking results.
According to the simulation results, the initial docked 
structure and the ultimate structure of the 3CLpro-glycy-
coumarin complex had been in a similar binding pocket and 
showed that ligand–protein conformation was stable after the 
simulation and docking results of the glycycoumarin with 
3CLpro was reliable. Figure 15 presents the structure super-
position of the complex following simulation. With regard to 
the 3D conformation results of glycycoumarin, the interac-
tion of a majority of the residues (Met 49, His41, Leu141, 
Phe140, Ser144, Asn142, Cys145, Gly143, Met165, His163, 
Gln189, and Glu166) and glycycoumarin in the initial 
docked and ultimate 3CLpro-glycycoumarin complex after 
50 ns simulations did not change. However, glycycoumarin 
form hydrogen bonds with the residues Cys145, Gln189 and 
Ser144 as well as novel hydrogen bonds with Thr25, Glu166 
and Asn142. Notably, the substituted coumarin area of the 
glycycoumarin could create hydrophobic interactions with 
the Phe140, Met41, Met165, and Leu141 residues. Hence, 
such a binding interaction would be beneficial to the cou-
marin compounds’ stability in the binding pocket of 3CLpro 
protein. Also, for investigation of the system condition dur-
ing simulation, the 3CLpro-glycycoumarin structure was 
extracted from trajectories for every 10 ns (Fig. S6). These 
snapshots proved the fixed orientation of glycycoumarin at 
the active site of the 3CLpro throughout the simulation.
Due to their natural origin, coumarin phytochemical 
enjoys several benefits such as potentially less side effects, 
lower toxicity, and issues regarding the administration of 
a majority of the synthetic and semi-synthetic medicines. 
Fig. 14  binding free energies 
of the residues which have 
considerable interactions with 
N3, Lopinavir, glycycoumarin, 



























According to the present research, glycycoumarin, oxypeu-
cedanin hydrate, and Inophyllum P compounds in addition 
to being of natural origin, drug-likely and particularly, hav-
ing antiviral properties, also displayed comparable bind-
ing energy values with that of N3 and lopinavir. There-
fore, further experimental investigations are suggested to 
explore probable preclinical and clinical efficiency of the 
phytochemicals like glycycoumarin oxypeucedanin hydrate 
and Inophyllum P to inhibit protease protein and treat 
COVID-19.
Future perspective
The potential for the emergence of novel CoVs and the 
mutating nature of CoVs in the future, make the develop-
ment of broad spectrum of the antivirals necessary. As future 
perspectives, research should aim at the development of pro-
tease inhibitor antiviral compounds, which play a crucial 
role in the fusion of the virus to the host cell membrane, 
suppressing the entry of the virus. Also, based on of these 
studies, future research should be conducted on the appli-
cation of already existing antiviral drugs, and plant-based 
traditional medicines on SARS-CoV-2 infected patients to 
find out if the expected benefits can be seen in the treat-
ment process. For this purpose, randomized controlled tri-
als should be carried out to obtain more accurate results. In 
addition, production of new vaccines and virus neutralizing 
antibodies to target the proposed viral molecular structures 
should be considered.
Conclusion
3-Chymotrypsin-like main protease (3CLpro) is an attrac-
tive target for the inhibition of the viral replication cycle 
and the treatment of SARS-CoV-2 infections. The aim of 
this study was to investigate the antiviral potential of a set 
of coumarin phytochemical compounds against coronavi-
rus 3CLpro using in silico approaches. These inhibitors 
could inhibit the 3CLpro with a highly conserved inhibi-
tory effect to both SARS-CoV2 and SARS-CoV. Among 
the studied 50 coumarin phytochemicals, glycycoumarin, 
Inophyllum P, mesuol and oxypeucedanin hydrate displayed 
the highest binding affinity with the best negative energy 
scores and interacted with one or both of the catalytic resi-
dues (His41 and Cys145) of 3CLpro through hydrophilic 
and hydrophobic bonding. MD results revealed that glycy-
coumarin, oxypeucedanin hydrate and Inophyllum P com-
pounds are stable within the active site of 3CLpro of SARS-
CoV-2 with significant binding free energies of − 60.31 kJ/
mol, − 58.86  kJ/mol, and − 57.75  kJ/mol and also, the 
pharmacokinetics and ADMET evaluation indicate their 
Fig. 15  Superposition of 
molecular docking result and 
MD structure of compound gly-
cycoumarin with 3CLpro after 
50 ns simulations. The residues 
of active site (pink), docked 
glycycoumarin (dark cyan) and 
MD glycycoumarin (olive drab)
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efficiency as drug molecules. Based on these findings, most 
of the coumarin phytochemicals can be used to design effec-
tive antiviral drugs against SARS-CoV-2.
Supplementary Information The online version contains supplemen-
tary material available at https:// doi. org/ 10. 1007/ s11030- 021- 10230-6.
Acknowledgements We are grateful to Clinical Biochemistry Research 
Center, Basic Health Sciences Institute; Shahrekord University of 
Medical Sciences for financial support of this research. The study was 
supported financially by the grant (No. 3364) provided by Shahrekord 
University of Medical Sciences and also was approved by the Ethics 
Committee of Shahrekord University of Medical Sciences (IR.SKUMS.
REC.1399.117).
Declarations 
Conflict of Interest The authors declare that they have no conflict of 
interest.
Ethical approval This article does not contain any study with human 
participants or animals performed by any of the authors.
References
 1. Chatterjee S, Maity A, Chowdhury S, Islam MA, Muttinini RK, 
Sen D (2020) In silico analysis and identification of promising 
hits against novel coronavirus 3C-like main protease enzyme. J 
Biomol Struct Dyn 2020:1–14. https:// doi. org/ 10. 1080/ 07391 102. 
2020. 17872 28
 2. Parvez M, Alam S, Karim M, Hasan M, Jaman J, Karim Z, Tahsin 
T, Hasan M, Hosen MJ (2020) Prediction of potential inhibitors 
for RNA-dependent RNA polymerase of SARS-CoV-2 using com-
prehensive drug repurposing and molecular docking approach. Int 
J Biol Macromole 163:1787–1797. https:// doi. org/ 10. 1016/j. ijbio 
mac. 2020. 09. 098
 3. Aanouz I, Belhassan A, El-Khatabi K, Lakhlifi T, El-Ldrissi M, 
Bouachrine M (2020) Moroccan medicinal plants as inhibitors 
against SARS-CoV-2 main protease: computational investiga-
tions. J Biomol Struct Dyn. https:// doi. org/ 10. 1080/ 07391 102. 
2020. 17587 90
 4. Schwartz DA, Graham AL (2020) Potential maternal and infant 
outcomes from (Wuhan) coronavirus 2019-nCoV infecting preg-
nant women: lessons from SARS, MERS, and other human coro-
navirus infections. Viruses 12(2):194. https:// doi. org/ 10. 3390/ 
v1202 0194
 5. Hui DS (2017) Epidemic and emerging coronaviruses (severe 
acute respiratory syndrome and Middle East respiratory syn-
drome). Clin Chest Med 38(1):71–86. https:// doi. org/ 10. 1016/j. 
ccm. 2016. 11. 007
 6. Reusken CB, Haagmans BL, Müller MA, Gutierrez C, Godeke 
G-J, Meyer B, Muth D, Raj VS, Smits-De Vries L, Corman VM 
(2013) Middle East respiratory syndrome coronavirus neutralising 
serum antibodies in dromedary camels: a comparative serological 
study. Lancet Infect Dis 13(10):859–866. https:// doi. org/ 10. 1016/ 
S1473- 3099(13) 70164-6
 7. Kallingal A, Thachan Kundil V, Ayyolath A, Karlapudi AP, 
Muringayil Joseph T (2020) Molecular modeling study of tecto-
quinone and acteoside from Tectona grandis linn: a new SARS-
CoV-2 main protease inhibitor against COVID-19. J Biomol 
Struct Dyn. https:// doi. org/ 10. 1080/ 07391 102. 2020. 18325 80
 8. Kodchakorn V, Poovorawan Y, Suwannakarn K, Kongtawelert P 
(2020) Molecular modelling investigation for drugs and nutra-
ceuticals against protease of SARS-CoV-2. J Mol Graph Model. 
https:// doi. org/ 10. 1016/j. jmgm. 2020. 107717
 9. Wu JT, Leung K, Leung GM (2020) Nowcasting and forecasting 
the potential domestic and international spread of the 2019-nCoV 
outbreak originating in Wuhan, China: a modelling study. The 
Lancet 395(10225):689–697. https:// doi. org/ 10. 1016/ S0140- 
6736(20) 30260-9
 10. Al-Rohaimi AH, Al Otaibi F (2020) Novel SARS-CoV-2 outbreak 
and COVID19 disease; a systemic review on the global pandemic. 
Genes Dis. https:// doi. org/ 10. 1016/j. gendis. 2020. 06. 004
 11. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, Mega-
wati D, Hayati Z, Wagner AL, Mudatsir M (2020) Coronavirus 
disease 2019 (COVID-19): a literature review. J Infect Pub Health. 
https:// doi. org/ 10. 1016/j. jiph. 2020. 03. 019
 12. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC 
(2020) Pathophysiology, transmission, diagnosis, and treatment 
of coronavirus disease 2019 (COVID-19): a review. JAMA 
324(8):782–793. https:// doi. org/ 10. 1001/ jama. 2020. 12839
 13. Lechien JR, Chiesa-Estomba CM, Place S, Van Laethem Y, Caba-
raux P, Mat Q, Huet K, Plzak J, Horoi M, Hans S (2020) Clinical 
and epidemiological characteristics of 1420 European patients 
with mild-to-moderate coronavirus disease 2019. J Intern Med. 
https:// doi. org/ 10. 1111/ joim. 13089
 14. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, 
Huang B, Zhu N (2020) Genomic characterisation and epidemiol-
ogy of 2019 novel coronavirus: implications for virus origins and 
receptor binding. The Lancet 395(10224):565–574. https:// doi. 
org/ 10. 1016/ S0140- 6736(20) 30251-8
 15. Islam R, Parves MR, Paul AS, Uddin N, Rahman MS, Mamun 
AA, Hossain MN, Ali MA, Halim MA (2020) A molecular mode-
ling approach to identify effective antiviral phytochemicals against 
the main protease of SARS-CoV-2. J Biomol Struct Dyn. https:// 
doi. org/ 10. 1080/ 07391 102. 2020. 17618 83
 16. Khan A, Ali SS, Khan MT, Saleem S, Ali A, Suleman M, Babar Z, 
Shafiq A, Khan M, Wei D-Q (2020) Combined drug repurposing 
and virtual screening strategies with molecular dynamics simula-
tion identified potent inhibitors for SARS-CoV-2 main protease 
(3CLpro). J Biomol Struct Dyn. https:// doi. org/ 10. 1080/ 07391 
102. 2020. 17791 28
 17. Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, 
Zhang L, Peng C (2020) Structure of M pro from SARS-CoV-2 
and discovery of its inhibitors. Nature. https:// doi. org/ 10. 1038/ 
s41586- 020- 2223-y
 18. Ghosh R, Chakraborty A, Biswas A, Chowdhuri S (2020) Identifi-
cation of alkaloids from Justicia adhatoda as potent SARS CoV-2 
main protease inhibitors: An in silico perspective. J Mol Struct. 
https:// doi. org/ 10. 1016/j. molst ruc. 2020. 129489
 19. Mishra S, Pandey A, Manvati S (2020) Coumarin: an emerging 
antiviral agent. Heliyon 6(1):e03217. https:// doi. org/ 10. 1016/j. 
heliy on. 2020. e03217
 20. Hassan MZ, Osman H, Ali MA, Ahsan MJ (2016) Therapeu-
tic potential of coumarins as antiviral agents. Eur J Med Chem 
123:236–255. https:// doi. org/ 10. 1016/j. ejmech. 2016. 07. 056
 21. Huang L, Zhe-Ling F, Yi-Tao W, Li-Gen L (2017) Anticancer 
carbazole alkaloids and coumarins from Clausena plants: a review. 
Chin J Nat Med 15(12):881–888. https:// doi. org/ 10. 1016/ S1875- 
5364(18) 30003-7
 22. Gonçalves GA, Spillere AR, Das Neves GM, Kagami LP, Von 
Poser GL, Canto RFS, Eifler-Lima VL (2020) Natural and syn-
thetic coumarins as antileishmanial agents: a review. Eur. J. Med. 
Chem 203:112514. https:// doi. org/ 10. 1016/j. ejmech. 2020. 112514
 23. Witaicenis A, Seito LN, da Silveira Chagas A, de Almeida Jun-
ior LD, Luchini AC, Rodrigues-Orsi P, Cestari SH, Di Stasi LC 
(2014) Antioxidant and intestinal anti-inflammatory effects of 
Molecular Diversity 
1 3
plant-derived coumarin derivatives. Phytomedicine 21(3):240–
246. https:// doi. org/ 10. 1016/j. phymed. 2013. 09. 001
 24. Zhou P, Takaishi Y, Duan H, Chen B, Honda G, Itoh M, Takeda 
Y, Kodzhimatov OK, Lee K-H (2000) Coumarins and bicoumarin 
from Ferula sumbul: anti-HIV activity and inhibition of cytokine 
release. Phytochemistry 53(6):689–697. https:// doi. org/ 10. 1016/ 
S0031- 9422(99) 00554-3
 25. Venugopala KN, Rashmi V, Odhav B (2013) Review on natu-
ral coumarin lead compounds for their pharmacological activity. 
Biomed Res Int. https:// doi. org/ 10. 1155/ 2013/ 963248
 26. Shikishima Y, Takaishi Y, Honda G, Ito M, Takeda Y, Kodzhi-
matov OK, Ashurmetov O, LEE KH (2001) Chemical constitu-
ents of Prangos tschimganica; structure elucidation and absolute 
configuration of coumarin and furanocoumarin derivatives with 
anti-HIV activity. Chem. Pharm. Bull. 49(7):877–880. https:// doi. 
org/ 10. 1248/ cpb. 49. 877
 27. Márquez N, Sancho R, Bedoya LM, Alcamí J, López-Pérez JL, 
San Feliciano A, Fiebich BL, Muñoz E (2005) a natural occur-
ring 4-phenylcoumarin, inhibits HIV-1 replication by targeting the 
NF-κB pathway. Antivir. Res. 66(2–3):137–145. https:// doi. org/ 
10. 1016/j. antiv iral. 2005. 02. 006
 28. Xu B, Wang L, González-Molleda L, Wang Y, Xu J, Yuan Y 
(2014) Antiviral activity of (+)-rutamarin against Kaposi’s sar-
coma-associated herpesvirus by inhibition of the catalytic activ-
ity of human topoisomerase II. Antimicrob Agents Chemother 
58(1):563–573. https:// doi. org/ 10. 1128/ AAC. 01259- 13
 29. Adianti M, Aoki C, Komoto M, Deng L, Shoji I, Wahyuni TS, 
Lusida MI, Fuchino H, Kawahara N, Hotta H (2014) Anti-hepa-
titis C virus compounds obtained from Glycyrrhiza uralensis and 
other Glycyrrhiza species. Microbiol Immunol 58(3):180–187. 
https:// doi. org/ 10. 1111/ 1348- 0421. 12127
 30. Perez RW (2003) Antiviral activity of compounds isolated from 
plants. Pharm Biol 41(2):107–157. https:// doi. org/ 10. 1076/ phbi. 
41.2. 107. 14240
 31. Chen Y, Yiu CPB, Wong K-Y (2020) Prediction of the SARS-
CoV-2 (2019-nCoV) 3C-like protease (3CL (pro)) structure: 
Virtual screening reveals velpatasvir, and other drug repurposing 
candidates. F1000Res. 9:129. https:// doi. org/ 10. 12688/ f1000 resea 
rch. 22457.2
 32. Said MA, Albohy A, m.A. abdelrahman, H.S. Ibrahim, (2021) 
Important of glutamine 189 flexibility in SARS-CoV-2 main 
protease: lesson learned from in silico virtual screening of 
ChEMBL database and molecular dynamicd. Eur. J. Pharm. Sci. 
160:105744. https:// doi. org/ 10. 1016/j. ejps. 2021. 105744
 33. Zaki AA, Al-Karmalawy AA, El-Amierc YA, Ashour A (2020) 
Molecular docking reveals the potential of Cleome amblyocarpa 
isolated compounds to inhibit COVID-19 virus main protease. 
New J Chem 44:16752–16758. https:// doi. org/ 10. 1039/ D0NJ0 
3611K
 34. Shah S, Chaple D, Arora S, Yende S, Mehta C, Nayak U (2020) 
Prospecting for cressa cretica to treat COVID-19 via in silico 
molecular docking models of the SARSCoV-2. J Biomol Struct 
Dy. https:// doi. org/ 10. 1080/ 07391 102. 2021. 18724 19
 35. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experi-
mental and computational approaches to estimate solubility and 
permeability in drug discovery and development settings. Adv 
Drug Deliv Rev 46(1–3):3. https:// doi. org/ 10. 1016/ S0169- 
409X(96) 00423-1
 36. Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kop-
ple KD (2002) Molecular properties that influence the oral bio-
availability of drug candidates. J Med Chem 45(12):2615–2623. 
https:// doi. org/ 10. 1021/ jm020 017n
 37. Egan WJ, Merz KM, Baldwin JJ (2000) Prediction of drug absorp-
tion using multivariate statistics. J Med Chem 43(21):3867–3877. 
https:// doi. org/ 10. 1021/ jm000 292e
 38. Muegge I, Heald SL, Brittelli D (2001) Simple selection criteria 
for drug-like chemical matter. J Med Chem 44(12):1841–1846. 
https:// doi. org/ 10. 1021/ jm015 507e
 39. Enmozhi SK, Raja K, Sebastine I, Joseph J (2020) Andro-
grapholide as a potential inhibitor of SARS-CoV-2 main protease: 
an in silico approach. J Biomol Struct Dyn. https:// doi. org/ 10. 
1080/ 07391 102. 2020. 17601 36
 40. Prasanth D, Murahari M, Chandramohan V, Panda SP, Atmakuri 
LR, Guntupalli C (2020) In silico identification of potential inhibi-
tors from Cinnamon against main protease and spike glycoprotein 
of SARS CoV-2. J Biomol Struct Dyn. https:// doi. org/ 10. 1080/ 
07391 102. 2020. 17791 29
 41. Abraham MJ, Murtola T, Schulz R, Páll S, Smith JC, Hess B, 
Lindahl E (2015) GROMACS: high performance molecular simu-
lations through multi-level parallelism from laptops to supercom-
puters. SoftwareX 1:19–25. https:// doi. org/ 10. 1016/j. softx. 2015. 
06. 001
 42. Ibrahim MAA, Abdelrahman AHM, Hussien T, Badr EAA, 
Mohamed TA, El-Seedi HR, Pare PW, Efferth T, Hegazy MEF 
(2020) In silico drug discovery of major metabolites from spices 
as SARS-CoV-2 main protease inhibitor. Comput Biol Med. 
https:// doi. org/ 10. 1016/j. compb iomed. 2020. 104046
 43. Kumar V, Dhanjal JK, Kaul SC, Wadhwa R, Sundar D (2020) 
Withanone and caffeic acid phenethyl ester are predicted to inter-
act with main protease (Mpro) of SARS-CoV-2 and inhibit its 
activity. J Biomol Struct Dyn. https:// doi. org/ 10. 1080/ 07391 102. 
2020. 17721 08
 44. Schüttelkopf AW, Van Aalten DM (2004) PRODRG: a tool for 
high-throughput crystallography of protein–ligand complexes. 
Acta Cryst D: Biol Crystal 60(8):1355–1363. https:// doi. org/ 10. 
1107/ S0907 44490 40116 79
 45. Pant S, Singh M, Ravichandiran V, Murty U, Srivastava HK 
(2020) Peptide-like and small-molecule inhibitors against Covid-
19. J Biomol Struct Dyn. https:// doi. org/ 10. 1080/ 07391 102. 2020. 
17575 10
 46. Elfiky AA, Azzam EB (2020) Novel Guanosine Derivatives 
against MERS CoV polymerase: an in silico perspective. J Biomol 
Struct Dyn. https:// doi. org/ 10. 1080/ 07391 102. 2020. 17587 89
 47. Umesh D, Kundu C, Selvaraj SK, Singh V.K. D. (2020) Identifi-
cation of new anti-nCoV drug chemical compounds from Indian 
spices exploiting SARS-CoV-2 main protease as target. J Biomol 
Struct Dyn. https:// doi. org/ 10. 1080/ 07391 102. 2020. 17632 02
 48. Aldeghi M, Bodkin MJ, Knapp S, Biggin PC (2017) Statistical 
analysis on the performance of Molecular Mechanics Poisson-
Boltzmann Surface Area versus absolute binding free energy 
calculations: bromodomains as a case study. J Chem Inf Model 
57(9):2203–2221. https:// doi. org/ 10. 1021/ acs. jcim. 7b003 47
 49. Genheden S, Ryde U (2015) The MM/PBSA and MM/GBSA 
methods to estimate ligand-binding affinities. Expert Opin Drug 
Discov 10(5):449–461. https:// doi. org/ 10. 1517/ 17460 441. 2015. 
10329 36
 50. R. Kumari, R. Kumar, O.S.D.D. Consortium, A. Lynn, g_mmpbsa 
A GROMACS tool for high-throughput MM-PBSA calcula-
tions, J. Chem. Inf. Model. 54(7) (2014) 1951-1962. https://doi.
org/https:// doi. org/ 10. 1021/ ci500 020m
 51. Yang H, Yang M, Ding Y, Liu Y, Lou Z, Zhou Z, Sun L, Mo L, Ye 
S, Pang H, Gao GF, Anand K, Bartlam M, Hilgenfeld R, Rao Z 
(2003) The crystal structures of severe acute respiratory syndrome 
virus main protease and its complex with an inhibitor. Proc Natl 
Acad Sci 100(23):13190–13195. https:// doi. org/ 10. 1073/ pnas. 
18356 75100
 52. El Sayed KA (2000) Natural products as antiviral agents studies 
in natural products chemistry. Elsevier, Amsterdam
 53. Reutrakul V, Leewanich P, Tuchinda P, Pohmakotr M, Jaipetch 
T, Sophasan S, Santisuk T (2003) Cytotoxic coumarins from 
 Molecular Diversity
1 3
Mammea harmandii. Planta Med 69(11):1048–1051. https:// doi. 
org/ 10. 1055/s- 2003- 45154
 54. Shikishima Y, Takaishi Y, Honda G, Ito M, Takfda Y, Kodzhi-
motov O, Ashurmetov O, Lee K (2001) Chemical constituents of 
prangos tschimganica; structure elucidation and absolute configu-
ration of coumarin and furano coumarin derivatives with anti-HIV 
activity. Chem Pharm Bull 49:877–880. https:// doi. org/ 10. 1248/ 
cpb. 49. 877
 55. Daina A, Michielin O, Zoete V (2017) SwissADME: a free web 
tool to evaluate pharmacokinetics, drug-likeness and medicinal 
chemistry friendliness of small molecules. Sci Rep 7:42717. 
https:// doi. org/ 10. 1038/ srep4 2717
 56. Al-Nour MY, Ibrahim MM, Elsaman T (2019) Ellagic acid, 
kaempferol, and quercetin from acacia nilotica: promising com-
bined drug with multiple mechanisms of action. Curr Pharmacol 
Rep 5:255–280. https:// doi. org/ 10. 1007/ s40495- 019- 00181-w
 57. Chinnasamy P, Arumugam R (2018) In silico prediction of anti-
carcinogenic bioactivities of traditional anti-inflammatory plants 
used by tribal healers in Sathyamangalam wildlife Sanctuary, 
India. Egypt J Basic Appl Sci 5(4):265–279. https:// doi. org/ 10. 
1016/j. ejbas. 2018. 10. 002
 58. Sethi P, Bansal Y, Bansal G (2018) Synthesis and PASS-assisted 
evaluation of coumarin-benzimidazole derivatives as poten-
tial anti-inflammatory and anthelmintic agents. Med Chem Res 
27:61–71. https:// doi. org/ 10. 1007/ s00044- 017- 2036-1
 59. Al-SharI NA (2020) Tackling COVID-19: identification of poten-
tial main protease inhibitors via structural analysis, virtual screen-
ing, molecular docking and MM-PBSA calculations. J Biomol 
Struct Dyn. https:// doi. org/ 10. 1080/ 07391 102. 2020. 18005 14
 60. Wang J (2020) Fast identification of possible drug treatment of 
coronavirus disease-19 (COVID-19) through computational drug 
repurposing study. J Chem Inf Model 60(6):3277–3286. https:// 
doi. org/ 10. 1021/ acs. jcim. 0c001 79
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
